Orum Therapeutics
Joanne Lim is an experienced immunologist with a distinguished career in the biopharmaceutical industry. Currently serving as Associate Director of Immunology at Orum Therapeutics, Joanne has previously held significant roles at Codiak BioSciences, including Principal Scientist and Senior Scientist in Immunology. Prior experience includes Investigator II and Investigator I positions focused on ImmunoOncology at Novartis Institutes for BioMedical Research (NIBR), and a postdoctoral fellowship at Dana-Farber/Harvard Cancer Center. Joanne started the research career at the University of Rochester Medical Center as a postdoctoral researcher and PhD candidate. Education includes a Doctor of Philosophy in Immunology and a Master’s degree in Immunology, both from the University of Rochester School of Medicine and Dentistry.
This person is not in any teams
This person is not in any offices
Orum Therapeutics
Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibodytherapeutics. In contrast to other approaches, Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification.